Author: Vanderbilt News and Communications
Oct. 7, 2003—Vanderbilt University Medical Center is participating in worldwide tests of a potential vaccine that can stimulate important immune responses against the virus that causes AIDS.
Aug. 7, 2003—Researchers have moved a step closer to finding a "molecular fingerprint" of an individual's cancer.
Aug. 7, 2003—In an effort to guard patient safety, VUMC is taking a leaf from American aviation, where it's been shown that human error and the harm it poses can be substantially reduced through training to improve communication among members of the flight crew.
Vanderbilt Children’s Hospital Study Finds Use of Automated External Defibrillators in Children Safe and Effective
Jul. 25, 2003—A research study performed at Vanderbilt Children's Hospital, proving the safety and effectiveness of using automated external defibrillators (AED's) in children, has helped change American Heart Association guidelines. The study will be published in the August 2003 issue of Annals of Emergency Medicine.
Jul. 9, 2003—As questions continue to swirl around President Bush's national smallpox vaccination plan, Vanderbilt University Medical Center is launching a new smallpox bandage trial that will help answer questions about one of the major issues associated with receiving the vaccine.
Jun. 17, 2003—Laurel Brown, PhD, assistant professor of psychiatry, is the principal investigator of a pilot study currently underway in The Vanderbilt Ingram Cancer Center, in conjunction with the Departments of Psychiatry and Psychology to uncover the cause of cognitive deficits many breast cancer patients experience after being treated with chemotherapy, often referred to as "chemo brain" or "chemo fog."
Jun. 12, 2003—A team of Vanderbilt-Ingram Cancer Center physician-scientists gathered with their colleagues here earlier this week to hear, discuss and present some of the latest advances in care for patients with cancer.
Jun. 4, 2003—The Vanderbilt-Ingram Cancer Center is now offering a technique that uses a light-activated drug to help restore the ability to swallow in patients whose esophagus is blocked by cancer.
May. 30, 2003—Vanderbilt University Medical Center has been ranked No. 3 worldwide in enrollment for an international trial testing the efficacy of a new immunosuppressant drug for use in heart transplant patients.